![Amy Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Sullivan
Geen lopende functies
Vermogen: 516 $ op 30-06-2026
Profiel
Ms. Amy B. Sullivan was previously employed as a Chief Financial & Accounting Officer by IO Biotech, Inc., a Chief Strategy Officer by Kiadis Pharma NV, a Senior Vice President-Corporate Affairs by Keryx Biopharmaceuticals, Inc., a VP-Corporate Communications & Investor Relations by AMAG Pharmaceuticals, Inc., a Head-Corporate Communications & Investor Relations by Genencor International, Inc., and a Head-Corporate Communications & Investor Relations by Idenix Pharmaceuticals LLC.
She received her undergraduate degree from Salem International University and an MBA from Bentley University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IO BIOTECH, INC. 0,12% | 11-04-2025 | 84.632 ( 0,12% ) | 516 $ | 30-06-2026 |
Eerdere bekende functies van Amy Sullivan
| Bedrijven | Functie | Einde |
|---|---|---|
| IO BIOTECH, INC. | Financieel Directeur/CFO | 31-03-2026 |
| KERYX BIOPHARMACEUTICALS | Public Communications Contact | - |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Investor Relations Contact | - |
| IDENIX PHARMACEUTICALS INC | Investor Relations Contact | - |
| KIADIS PHARMA N.V. | Investor Relations Contact | - |
Opleiding van Amy Sullivan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
48
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Salem International University
 Salem International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
